Effective inventory control is essential for pharmaceutical companies to maintain product quality, regulatory compliance, and operational efficiency. Slingshot Pharma’s cGMP Inventory Control solution is designed specifically to support the complex material management requirements of pharmaceutical manufacturing.The solution provides lot-based material control, allowing companies to manage materials through statuses such as Quarantine, Released, Rejected, and Expired. Testing and expiry dates can be tracked automatically, helping prevent the use of materials that are no longer approved for production. Comprehensive audit trails also record inventory transactions, user activities, reasons for changes, and electronic signatures, supporting a 21 CFR Part 11-compliant environment.For pharmaceutical organizations handling temperature-sensitive materials, the system supports cold-chain inventory management. Environmental requirements, including temperature and humidity, can be defined for materials and warehouse zones, while alerts can notify users when time-out-of-temperature limits are approaching.The platform also supports multiple units of measure, material ownership tracking, cycle counting, stock replenishment, equipment maintenance workflows, and intra-plant material transfers. These capabilities provide greater visibility and control over pharmaceutical inventory operations while helping organizations maintain accurate, traceable records.Visit - https://www.slingshotpharma.com/cgmp-inventory-control